Magliulo Eric, Tendulkar Ketki, Samson Kaeli, Khan Saber, Birch Nathan
University of Nebraska Medical Center, Omaha, NE, USA.
Creighton University School of Medicine, Omaha, NE, USA.
Am J Hosp Palliat Care. 2025 Nov;42(11):1212-1214. doi: 10.1177/10499091241301754. Epub 2024 Nov 19.
End stage kidney disease (ESKD) patients until recently have been effectively excluded from receiving hospice benefits unless they withdraw from renal replacement therapy. Policy change has allowed select populations to receive concurrent hospice and hemodialysis. We conducted a retrospective analysis of all deaths occurring from 2019 to 2022 among outpatient hemodialysis patients at our VA medical center. We compared clinical data and resource utilization between patients that were enrolled in concurrent hospice vs patients that were not enrolled in hospice. Our data suggests that among the hemodialysis population, enrollment in concurrent hospice services was not associated with increased healthcare resource utilization. This information may help increase enrollment in hospice among dialysis patients and promote optimal end of life care.
直到最近，终末期肾病（ESKD）患者实际上一直被排除在接受临终关怀福利之外，除非他们停止接受肾脏替代治疗。政策变化使得特定人群能够同时接受临终关怀和血液透析。我们对2019年至2022年期间在我们退伍军人事务部医疗中心接受门诊血液透析的患者的所有死亡病例进行了回顾性分析。我们比较了同时登记接受临终关怀的患者和未登记接受临终关怀的患者之间的临床数据和资源利用情况。我们的数据表明，在血液透析人群中，同时登记接受临终关怀服务与医疗资源利用增加无关。这些信息可能有助于提高透析患者对临终关怀的登记率，并促进最佳的临终护理。
